Oral contraception and unprotected sex with occasional partners of women HIV-infected through injection drug use

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 18, Issue 7, 2006, Pages 795-800

  Carrieri, M P ^a   Rey, D ^b   Serraino, D ^c   Tremolieres F ^d   Mechali D ^e   Moatti, J P ^a   Spire, B ^a  

^a INSERM   (France)

^b OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

^c NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^d HENRI MONDOR HOSPITAL   (France)

^e DELAFONTAINE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BUPRENORPHINE; COCAINE; METHADONE;

ADULT; ARTICLE; CONDOM; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG USE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; ORAL CONTRACEPTION; PRIORITY JOURNAL; PUBLIC HEALTH; RISK REDUCTION; SEXUAL BEHAVIOR; SEXUALITY; STATISTICAL MODEL; UNSAFE SEX;

ADULT; CONTRACEPTIVES, ORAL; FEMALE; HIV INFECTIONS; HUMANS; SEXUAL PARTNERS; SUBSTANCE ABUSE, INTRAVENOUS; UNSAFE SEX;

EID: 33748708820     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120500431584     Document Type: Article

References (41)

1. The CASCADE Collaboration (2000). Survival after introduction of HAART in people with known duration of HIV-1 infection. Concerted Action on SeroConversion to AIDS and Death in Europe. Lancet, 355, 1158-1159.
2. Centers For Disease Control And Prevention (2001). Scientific evidence on condom effectiveness for sexually transmitted disease preventions. Hyatt Dulles Airport, Herndon, Virginia.
3. Anderson, J.E., Brackbill, R., & Mosher, W.D. (1996). Condom use for disease prevention among unmarried U.S. women. Family Planning Perspectective, 28, 25-28.
4. Bedimo, A.L., Bennett, M., Kissinger, P., & Clark, R.A. (1998). Understanding barriers to condom usage among HIV-infected African American women. Journal of Associated Nurses for AIDS Care, 9, 48-58.
5. Booth, R.E., Crowley, T.J., & Zhang, Y. (1996). Substance abuse treatment entry, retention and effectiveness: out-of-treatment opiate injection drug users. Drug and Alcohol Dependence, 42, 11-20.
6. Carrieri, M.P., Moatti, J.P., Vlahov, D., Obadia, Y., Reynaud-Maurupt, C., & Chesney, M. (1999). Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group. Journal of Epidemiology and Community Health, 53, 4-8.
7. Carrieri, P., Spire, B., Duran, S., Katlama, C., Peyramond, D., Francois, C., Chene, G., Lang, J.M., Moatti, J.P., & Leport, C. (2003). Health-related quality of life after 1 year of highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndrome, 32, 38-47.
8. Castilla, J., Barrio, G., Belza, M.J., & de la Fuente, L. (1999). Drug and alcohol consumption and sexual risk behaviour among young adults: results from a national survey. Drug and Alcohol Dependence, 56, 47-53.
9. Clark, R.A., Kissinger, P., Bedimo, A.L., Dunn, P., & Albertin, H. (1997). Determination of factors associated with condom use among women infected with human immunodeficiency virus. International Journal of STD & AIDS, 8, 229-233.
10. Crepaz, N., Hart, T.A., & Marks, G. (2004). Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. Journal of American Medical Association, 292, 224-236.
11. Darke, S. (1998). Self-report among injecting drug users: a review. Drug and Alcohol Dependence, 51, 253-263; discussion 67-68.
12. Desquilbet, L., Deveau, C., Goujard, C., Hubert, J.B., Derouineau, J., & Meyer, L. (2002). Increase in at-risk sexual behaviour among HIV-1-infected patients followed in the French PRIMO cohort. Aids, 16, 2329-2333.
13. Diaz, T., Schable, B., & Chu, S.Y. (1995). Relationship between use of condoms and other forms of contraception among human immunodeficiency virus-infected women. Supplement to HIV and AIDS Surveillance Project Group. Obstetrics and Gynecology, 86, 277-282.
14. Dolezal, C., Ehrhardt, A.A., Meyer-Bahlburg, H.F., Liu, X., Exner, T.M., Rabkin, J.G., Gorman, J.M., Marder, K., & Stern, Y. (1998). Sexual risk behavior changes among HIV+ and HIV-female injecting drug users over 4 years. Women Health, 27, 1-17.
15. Fleisher, J.M., Senie, R.T., Minkoff, H., & Jaccard, J. (1994). Condom use relative to knowledge of sexually transmitted disease prevention, method of birth control, and past or present infection. Journal of Community Health, 19, 395-407.
16. Fuhrer, R., & Rouillon, F. (1989). La version française de l'échelle CES-D. Description and translation of the autoevaluation scale (in French). Psychiatrie et Psychobiologie, 4, 163-166.
17. Gremy, I., & Beltzer, N. (2001). Knowledge, Attitudes, Behaviors, and Practices towards HIV/AIDS in France. Evolution 1992-1994-1998-2001. National Agency for Aids Research, Health Ministry, ed ORS Ile de France, Paris.
18. Hader, S.L., Smith, D.K., Moore, J.S., & Holmberg, S.D. (2001). HIV infection in women in the United States: status at the Millennium. Journal of American Medical Association, 285, 1186-1192.
19. Heard, I., Potard, V., Costagliola, D., & Kazatchkine, M.D. (2004). Contraceptive Use in HIV-Positive Women. Journal of Acquired Immune Deficiency Syndrome, 36, 714-720.
20. Holmberg, S.D. (1996). The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. American Journal Public Health, 86, 642-654.
21. INVS (Institut National de Veille Sanitaire) (2004). Premiers résultats du nouveau dispositif de surveillance de l'infection à VIH et situation du SIDA au 30 septembre 2003. Bulletin Epidémiologique Hebdomadaire, 24-25, 102-109.
22. Kelly, J.A., Murphy, D.A., Bahr, G.R., Koob, J.J., Morgan, M.G., Kalichman, S.C., Stevenson, L.Y., Brasfield, T.L., Bernstein, B.M., & St Lawrence, J.S. (1993). Factors associated with severity of depression and high-risk sexual behavior among persons diagnosed with human immunodeficiency virus (HIV) infection. Health Psychology, 12, 215-219.
23. Klevens, R.M., Fleming, P.L., Neal, J.J., & Li, J. (2001). Knowledge of partner risk and secondary transmission of HIV. American Journal of Preventive Medicine, 20, 277-281.
24. Latkin, C.A., Knowlton, A.R., Forman, V.L., Hoover, D.R., Schroeder, J.R., Hachey, M., & Celentano, D. (2001). Injection drug users' disclosure of HIV seropositive status to network members. AIDS and Behavior, 5, 297-305.
25. Latkin, C.A., & Vlahov, D. (1998). Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users. Addiction, 93, 1191-1197.
26. McElrath, K., Chitwood, D.D., Griffin, D.K., & Comerford, M. (1994). The consistency of self-reported HIV risk behavior among injection drug users. American Journal of Public Health, 84, 1965-1970.
27. Novotna, L., Wilson, T.E., Minkoff, H.L., McNutt, L.A., DeHovitz, J.A., et al. (1999). Predictors and risk-taking consequences of drug use among HIV-infected women. Journal of Acquired Immune Deficiciency Syndrome and Human Retrovirology, 20, 502-507.
28. Prentice, R.L. (1988). Correlated binary regression with covariates specific to each binary observation. Biometrics, 44, 1033-1048.
29. Reilly, T., & Woo, G. (2001). Predictors of high risk behavior among people living with HIV/AIDS. AIDS and Behaviors, 5, 205-217.
30. Scheer, S., Chu, P.L., Klausner, J.D., Katz, M.H., & Schwarcz, S.K. (2001). Effect of highly active antiretroviral therapy on diagnoses of sexually transmitted diseases in people with AIDS. Lancet, 357, 432-435.
31. Stolte, I.G., Dukers, N.H., Geskus, R.B., Coutinho, R.A., & de Wit, J.B. (2004). Homosexual men change to risky sex when perceiving less threat of HIV/AIDS since availability of highly active antiretroviral therapy: a longitudinal study. Aids, 18, 303-309.
32. Toulemon, L., & Leridon, H. (1998). Contraceptive practices and trends in France. Family Planning Perspective, 30, 114-120.
33. Trussel, J. (1998). Contraceptive efficacy. In R.A. Hatcher et al. ed. C Technology, pp. 779-844. New York: Ardent Media, 17th Revised Ed.
34. Tun, W., Gange, S.J., Vlahov, D., Strathdee, S.A., & Celentano, D.D. (2004). Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users. Clinical Infectious Disease, 38, 1167-1174.
35. van Empelen, P., Schaalma, H.P., Kok, G., & Jansen, M.W. (2001). Predicting condom use with casual and steady sex partners among drug users. Health Education Research, 16, 293-305.
36. Vincent, E., Bouhnik, A.D., Carrieri, M.P., Rey, D., Dujardin, P., Granier, F., Fuzibet, J.G., Obadia, Y., Moatti, J.P., & Spire, B. (2004). Impact of HAART-related side effects on unsafe sexual behaviours in HIV-infected injecting drug users: 7-year follow up. Aids, 18, 1321-1325.
37. Warszawski, J., & Meyer, L. (1998). Gender difference in persistent at-risk sexual behavior after a diagnosed sexually transmitted disease. ACSF-Investigators. Sexually Transmitted Diseases, 25, 437-442.
38. Wilson, T.E., Gore, M.E., Greenblatt, R., Cohen, M., Minkoff, H., Silver, S., Robison, E., Levine, A., & Gange, S.J. (2004). Changes in sexual behavior among HIV-infected women after initiation of HAART. American Journal of Public Health, 94, 1141-1146.
39. Wilson, T.E., Massad, L.S., Riester, K.A., Barkan, S., Richardson, J., Young, M., Gurtman, A., & Greenblatt, R. (1999). Sexual, contraceptive, and drug use behaviors of women with HIV and those at high risk for infection: results from the Women's Interagency HIV Study. Aids, 13, 591-598.
40. Wilson, T.E., & Minkoff, H. (2001). Brief report: condom use consistency associated with beliefs regarding HIV disease transmission among women receiving HIV antiretroviral therapy. Journal Acquired Immune Deficiciency Syndrome, 27, 289-291.
41. Wolf, K., Young, J., Rickenbach, M., Vernazza, P., Flepp, M., Flepp,M., Furrer, H., Bernasconi, E., Hirschel, B., Telenti, A., Weber, R., & Bucher, H.C. (2003). Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort Study. Journal Acquired Immune Deficiency Syndrome, 33, 494-499.